OnDemand: March 2025 Grand Rounds - A Ripple in the Epidemic: Developmental Origins of Obesity
Availability
On-Demand
Cost
Member: $0.00
Non-Member: $50.00
Credit Offered
1 AMA PRA Category 1 Credit
The impacts of maternal obesity in offspring health have been extensively studied in epidemiologic, interventional, and animal research. This talk will discuss clinical and public health strategies and challenges to preventing and mitigating intergenerational effects of maternal obesity during preconception, pregnancy, and postnatal phases of the life course.
1. After participating in the webinar, learners will understand the opportunities and challenges of clinical and public health strategies for reducing maternal adiposity before and during pregnancy.
2. By the end of this learning activity, learners will be able to discuss the potential implications of intergenerational processes for childhood obesity prevention strategies
3. Learners will be able to apply this knowledge to identify opportunities for intervention in patients with sub-optimal gestational weight gain in order to mitigate adverse outcomes in their offspring.
Janne Boone-Heinonen PhD, MPH, FTOS
Professor, University of California San Francisco
Dr. Janne Boone-Heinonen is a Professor at University of California San Francisco where her focus is on early life and contextual determinants of obesity in diverse populations. She received her PhD in Nutrition Epidemiology from the University of North Carolina at Chapel Hill in 2009, where she also completed a Interdisciplinary Obesity Postdoctoral Fellowship, and was on the faculty at Oregon Health & Science University in 2011-2024.
The Obesity Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Obesity Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Activity ID 202923682
Date of Release: April 1, 2025
Date of Termination: December 31, 2027
No commercial support was received for this activity.
Janne Boone-Heinonen, PhD, MPH, FTOS: No relevant financial relationships.
Jonathan Purnell, MD, FTOS: Consultation Relationship with Novo Nordisk (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), and Luciole (Pharmaceuticals).
No members of the TOS CME Oversight Committee, charged with the resolution of all relevant conflicts of interest, had any relevant financial relationships while serving on the committee.
1. Boone-Heinonen J, Dinh D, Springer R, Liu S, O'Malley J, Rosenquist NA, Schmidt T, Snowden JM, Tran ST, Vesco KK. Trimester-specific rate of gestational weight loss or gain and birth size: differences by prepregnancy BMI. Obesity (Silver Spring). 2024 Sep;32(9):1757-1768. doi: 10.1002/oby.24071. Epub 2024 Jul 30. PMID: 39081012; PMCID: PMC11357887.
2. Booman A, Vesco KK, Springer R, Dinh D, Liu S, Lyon-Scott K, Marino M, O'Malley J, Palma A, Schmidt T, Snowden JM, Stratton K, Tran ST, Boone-Heinonen J. Methods for modeling gestational weight gain: empirical application using electronic health record data from a safety net population. BMC Pregnancy Childbirth. 2025 Jan 17;25(1):35. doi: 10.1186/s12884-025-07139-5. PMID: 39825224; PMCID: PMC11740392.
Powered By